A draft bill amending Myanmar 1993 Narcotic Drugs and Psychotropic Substances Law was published in newspapers in March 2017 for public consultation. It was subsequently discussed in the upper house of Parliament (Amyothar Hluttaw) on 16 August 2017.
Myanmar is better known for its serious drug problems - including large-scale illicit drugs production and trafficking and high rates of heroin use - than for implementing progressive drug policies that prioritise the health of its population. However, this could change in the near future.
Drug users from Kachin came together last November to discuss the challenges and difficulties they experience and identify possible solutions to their problems. Read their statement and recommendations.
To address its serious drug use problems, Myanmar should change its drug policy towards a harm reduction approach. Instead of a repressive approach, voluntary and evidence-based treatment and public health services, including harm reduction, should be made available and become generally accepted by enforcement officials and by the community at large.
Opium farmers and representatives of their communities came together to discuss the challenges they face in their lives, and to share experiences and find ways to solve their problems. This is their statement.
The 7th GIZ/TNI Asian Informal Drug Policy Dialogue was organised in collaboration with the National Authority for Combating Drugs (NACD) of the Cambodian Government. Key issues on the agenda were recent trends in the drug market in the region and the development of effective policy responses. Specific attention went to the implementation of the UN Guiding Principles on Alternative Development in the Asian context, including in the implementation of alternative development programmes in conflict areas. The involvement of affected communities in policy making and project implementation was another important theme that was discussed. A major aim of the dialogue was to look at the state of the Asian drug policy before UNGASS 2016.